Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2022

25-06-2022 | Chronic Inflammatory Bowel Disease | Invited Review

Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review

Authors: Ricardo G. Suarez, Alvaro R. Osornio-Vargas, Eytan Wine

Published in: Digestive Diseases and Sciences | Issue 9/2022

Login to get access

Abstract

To review and discuss recent findings on the associations between pediatric/early-life exposures to ambient air pollution and the risk of pediatric-onset inflammatory bowel diseases (IBD). A scoping review was conducted using the Peters Micah et al. framework. We searched, selected, extracted, and reviewed information from published peer-reviewed papers from three bibliographic databases, chosen to cover a broad range of disciplines. Limits on date (last decade), language, and subject were placed on the database search. The search identified 109 papers from 2010 to June 2021. After screening, we identified nine articles with data on air pollution as a risk factor for IBD, but only four epidemiologic studies directly investigated the association between air pollution and IBD development in children and young adults. These four papers show that air pollution components have different associations with pediatric IBD (pIBD) incidence. Consequently, sulfur dioxide (SO2), nitrogen dioxide (NO2), and the oxidant capacity of air pollution (Ox) were positively associated with pIBD incidence, whereas the association effects of particulate matter (PM) and ozone (O3) exposures were not clear. Despite good scientific rationale and some studies, the evidence on the role that air pollution has in IBD development is limited, highlighting the need for further investigation. Future studies should include the epidemiology of air pollutants and its sources, identifying and understanding mechanisms linking air pollution and pIBD, and identifying signatures of biological responses to air pollutants.

Graphical Abstract

Literature
1.
Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769–2778.PubMedCrossRef
2.
Coward S, Clement F, Benchimol EI et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology. 2019;156:1345–1353.PubMedCrossRef
3.
Kuenzig ME, Fung SG, Marderfeld L et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology. 2022;162:1147–1159.PubMedCrossRef
4.
Benchimol EI, Bernstein CN, Bitton A et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112:1120–1134.PubMedPubMedCentralCrossRef
5.
6.
Aujnarain A, Mack DR, Benchimol EI. The role of the environment in the development of pediatric inflammatory bowel disease. Curr Gastroenterol Rep. 2013;15:326.PubMedCrossRef
7.
Strisciuglio C, Giugliano F, Martinelli M et al. Impact of environmental and familial factors in a cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2017;64:569–574.PubMedCrossRef
8.
Kugathasan S, Judd RH, Hoffmann RG et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525–531.PubMedCrossRef
9.
Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.PubMedCrossRef
10.
Rogler G, Vavricka S. Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm Bowel Dis. 2015;21:400–408.PubMedCrossRef
11.
Renz H, Holt PG, Inouye M, Logan AC, Prescott SL, Sly PD. An exposome perspective: Early-life events and immune development in a changing world. J Allergy Clin Immunol. 2017;140:24–40.PubMedCrossRef
12.
Ritz SA. Air pollution as a potential contributor to the ‘epidemic’ of autoimmune disease. Med Hypotheses. 2010;74:110–117.PubMedCrossRef
13.
Kish L, Hotte N, Kaplan GG et al. Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS ONE. 2013;8:e62220.PubMedPubMedCentralCrossRef
14.
Ananthakrishnan AN, Bernstein CN, Iliopoulos D et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15:39–49.PubMedCrossRef
15.
Örtqvist AK, Lundholm C, Halfvarson J, Ludvigsson JF, Almqvist C. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut. 2019;68:218–225.PubMedCrossRef
16.
Chua HH, Chou HC, Tung YL et al. Intestinal dysbiosis featuring abundance of Ruminococcus gnavus associates with allergic diseases in infants. Gastroenterology. 2018;154:154–167.PubMedCrossRef
17.
Yassour M, Jason E, Hogstrom LJ et al. Strain-level analysis of mother-to-child bacterial transmission during the first few months of life. Cell Host Microbe. 2018;24:146–154.PubMedPubMedCentralCrossRef
18.
Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22:713–722.PubMedCrossRef
19.
20.
Korpela K, Helve O, Kolho KL et al. Maternal fecal microbiota transplantation in cesarean-born infants rapidly restores normal gut microbial development: a proof-of-concept study. Cell. 2020;183:324–334.PubMedCrossRef
21.
Shouval DS, Rufo PA. The role of environmental factors in the pathogenesis of inflammatory bowel diseases. JAMA Pediatr. 2017;171:999–1005.PubMedCrossRef
22.
Baron S, Turck D, Leplat C et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005;54:357–363.PubMedPubMedCentralCrossRef
23.
Bager P, Simonsen J, Nielsen NM, Frisch M. Cesarean section and offspringʼs risk of inflammatory bowel disease: a national cohort study. Inflamm Bowel Dis. 2012;18:857–862.PubMedCrossRef
24.
Sonntag B, Stolze B, Heinecke A et al. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm Bowel Dis. 2007;13:1385–1390.PubMedCrossRef
25.
Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr. 2009;155:421–426.PubMedCrossRef
26.
Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101:993–1002.PubMedCrossRef
27.
Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci. 1994;39:555–560.PubMedCrossRef
28.
Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Environmental factors and risk of developing paediatric inflammatory bowel disease—a population based study 2007–2009. J Crohns Colitis. 2013;7:79–88.PubMedCrossRef
29.
Rodríguez LAG, Ruigómez A, Panés J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006;130:1588–1594.CrossRef
30.
Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol. 2000;95:171–176.PubMedCrossRef
31.
Carroll MW, Kuenzig ME, Mack DR et al. The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD. J Can Assoc Gastroenterol. 2019;2:S49–S67.PubMedCrossRef
32.
Andersen V, Olsen A, Carbonnel F, Tjønneland A, Vogel U. Diet and risk of inflammatory bowel disease. Dig Liv Dis. 2012;44:185–194.CrossRef
33.
El Amrousy D, El Ashry H, Hodeib H, Hassan S. Vitamin D in children with inflammatory bowel disease. J Clin Gastroenterol. 2021;55:815–820.PubMed
34.
Hasosah M, Alhashmi W, Abualsaud R et al. Environmental risk factors for childhood inflammatory bowel diseases: a multicenter case-control study. Children (Basel). 2022;9:4–12.
35.
Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49:643–654.PubMedCrossRef
36.
Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018;67:1726–1738.PubMedCrossRef
37.
38.
Cohen AJ, Brauer M, Burnett R et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389:1907–1918.PubMedPubMedCentralCrossRef
39.
Mukherjee A, Agrawal M. A global perspective of fine particulate matter pollution and its health effects. Rev Environ Contam Toxicol. 2018;244:5–51.PubMed
40.
Bazyar J, Pourvakhshoori N, Khankeh H, Farrokhi M, Delshad V, Rajabi E. A comprehensive evaluation of the association between ambient air pollution and adverse health outcomes of major organ systems: a systematic review with a worldwide approach. Environ Sci Pollut Res. 2019;26:12648–12661.CrossRef
41.
Jacquemin B, Siroux V, Sanchez M et al. Ambient air pollution and adult asthma incidence in six European cohorts (ESCAPE). Environ Health Perspect. 2015;123:613–621.PubMedPubMedCentralCrossRef
42.
Heydarpour P, Amini H, Khoshkish S, Seidkhani H, Sahraian MA, Yunesian M. Potential impact of air pollution on multiple sclerosis in Tehran, Iran. Neuroepidemiology. 2014;43:233–238.PubMedCrossRef
43.
Beamish LA, Osornio-Vargas AR, Wine E. Air pollution: an environmental factor contributing to intestinal disease. J Crohns Colitis. 2011;5:279–286.PubMedCrossRef
44.
Vignal C, Guilloteau E, Gower C, Body M. Review article: epidemiological and animal evidence for the role of air pollution in intestinal diseases. Sci Total Environ. 2021;757:143718.PubMedCrossRef
45.
Ran Z, An Y, Zhou J et al. Subchronic exposure to concentrated ambient PM2.5 perturbs gut and lung microbiota as well as metabolic profiles in mice. Environmen Pollution. 2021;272:115987.CrossRef
46.
Ribière C, Peyret P, Parisot N et al. Oral exposure to environmental pollutant benzo[a]pyrene impacts the intestinal epithelium and induces gut microbial shifts in murine model. Sci Rep. 2016;6:31027.PubMedPubMedCentralCrossRef
47.
Chen L, Zhang W, Hua J et al. Dysregulation of intestinal health by environmental pollutants: involvement of the estrogen receptor and aryl hydrocarbon receptor. Environmen Sci Technol. 2018;52:2323–2330.CrossRef
48.
Lavigne É, Bélair A, Rodriguez D et al. Effect modification of perinatal exposure to air pollution and childhood asthma incidence. Euro Respir J. 2018;51:1701884.CrossRef
49.
Peters M, Godfrey C, McInerney P, Munn Z, Trico A, Khalil H. Chapter 11: Scoping Reviews. In: JBI Manual for evidence synthesis. JBI; 2020.
50.
51.
Gawda A, Majka G, Nowak B, Marcinkiewicz J. Air pollution, oxidative stress, and exacerbation of autoimmune diseases. Centr Eur J Immunol. 2017;3:305–312.CrossRef
52.
Gruzieva O, Merid SK, Gref A et al. Exposure to traffic-related air pollution and serum inflammatory cytokines in children. Environmen Health Perspect. 2017;125:067007.CrossRef
53.
54.
Kaplan GG, Hubbard J, Korzenik J et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterology. 2010;105:2412–2419.CrossRef
55.
Opstelten JL, Beelen RMJ, Leenders M et al. Exposure to ambient air pollution and the risk of inflammatory bowel disease: a European nested case-control study. Dig Dis Sci. 2016;61:2963–2971.PubMedPubMedCentralCrossRef
56.
Alderete TL, Jones RB, Chen Z, Kim JS et al. Exposure to traffic-related air pollution and the composition of the gut microbiota in overweight and obese adolescents. Environ Res. 2018;161:472–478.PubMedPubMedCentralCrossRef
57.
Liu T, Chen X, Xu Y et al. Gut microbiota partially mediates the effects of fine particulate matter on type 2 diabetes: evidence from a population-based epidemiological study. Environ Intern. 2019;130:104882.CrossRef
58.
Lehtinen P, Pasanen K, Kolho L, Auvinen A. Incidence of pediatric inflammatory bowel disease in finland: an environmental study. J Pediatr Gastroenterol Nut. 2016;63:1778–1783.CrossRef
59.
Elten M, Benchimol EI, Fell DB et al. Ambient air pollution and the risk of pediatric-onset inflammatory bowel disease: a population-based cohort study. Environ Int. 2020;138:105676.PubMedCrossRef
60.
Elten M, Benchimol EI, Fell DB et al. Residential greenspace in childhood reduces risk of pediatric inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2021;116:347–353.PubMedCrossRef
61.
Benchimol EI, Manuel DG, To T et al. Asthma, type 1 and type 2 diabetes mellitus, and inflammatory bowel disease amongst South Asian immigrants to Canada and their children: a population-based cohort study. PLoS ONE. 2015;10:e0123599.PubMedPubMedCentralCrossRef
62.
Landrigan PJ, Sly JL, Ruchirawat M et al. Health consequences of environmental exposures: changing global patterns of exposure and disease. Ann Global Health. 2016;82:10–19.CrossRef
63.
64.
Noverr MC, Huffnagle GB. The “microflora hypothesis” of allergic diseases. Clin Exp Allergy. 2005;35:1511–1520.PubMedCrossRef
65.
66.
67.
Alam MT, Amos GCA, Murphy ARJ, Murch S, Wellington EMH, Arasaradnam RP. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut Pathog. 2020;12:1.PubMedPubMedCentralCrossRef
68.
Mutlu EA, Engen PA, Soberanes S et al. Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice. Part Fibre Toxicol. 2011;8:8–19.CrossRef
69.
Li X, Cui J, Yang H et al. Colonic injuries induced by inhalational exposure to particulate-matter air pollution. Advanced Sci. 2019;6:1900180.CrossRef
70.
Mutlu EA, Comba IY, Cho T et al. Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome. Environ Pollut. 2018;240:817–830.PubMedPubMedCentralCrossRef
71.
Fu P, Bai L, Cai Z, Li R, Yung KKL. Fine particulate matter aggravates intestinal and brain injury and affects bacterial community structure of intestine and feces in Alzheimer’s disease transgenic mice. Ecotoxicol Environ Saf. 2020;192:110325.PubMedCrossRef
72.
Salim SY, Jovel J, Wine E et al. Exposure to ingested airborne pollutant particulate matter increases mucosal exposure to bacteria and induces early onset of inflammation in neonatal IL-10-deficient mice. Inflamm Bowel Dis. 2014;20:1129–1138.PubMedCrossRef
73.
Reiss R, Anderson EL, Cross CE et al. Evidence of health impacts of sulfate-and nitrate-containing particles in ambient air. Inhal Toxicol. 2007;19:419–449.PubMedCrossRef
74.
Imathiu S. Street vended foods: potential for improving food and nutrition security or a risk factor for food borne diseases in developing countries? Current Research in Nutrition and Food Science Journal. 2017;5:55–65.CrossRef
75.
Alimi BA. Risk factors in street food practices in developing countries: a review. Food Sci. Hum. Wellness. 2016;5:141–148.CrossRef
76.
Mazzeo N. Chemistry, emission control, radioactive pollution and indoor air quality [Internet]. London: IntechOpen; 2011.CrossRef
77.
Ruiz T, Acuña JJ, Fujiyoshi S et al. Airborne bacterial communities of outdoor environments and their associated influencing factors. Environ Intern. 2020;145:106156.CrossRef
78.
Vester MK, Mirsepasi HC, Prosberg MV et al. Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis. Sci Rep. 2019;9:13473.CrossRef
79.
Fujimura KE, Demoor T, Rauch M et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci U S A. 2014;111:805–810.PubMedCrossRef
80.
Cholapranee A, Ananthakrishnan AN. Environmental hygiene and risk of inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22:2191–2199.PubMedCrossRef
81.
Vedamurthy A, Ananthakrishnan AN. Influence of environmental factors in the development and outcomes of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2019;2:72–82.
82.
83.
Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010;11:134–147.PubMedCrossRef
84.
Mannucci P, Franchini M. Health effects of ambient air pollution in developing countries. Int J Environ Res Public Health. 2017;14:1048.PubMedCentralCrossRef
85.
Thia KT, Loftus EV, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–3182.PubMedCrossRef
86.
Gancarczyk M. Enterprise- and industry-level drivers of cluster evolution and their outcomes for clusters from developed and less-developed countries. Eur Plan Stud. 2015;23:1–21.CrossRef
87.
Williams ML. Patterns of air pollution in developed countries. London: Academic Press; 1999.CrossRef
88.
Ryan FJ, Ahern AM, Fitzgerald RS et al. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nat Commun. 2020;11:15342.
89.
Fouladi F, Bailey MJ, Patterson WB et al. Air pollution exposure is associated with the gut microbiome as revealed by shotgun metagenomic sequencing. Environ Inter. 2020;138:1937–1943.CrossRef
Metadata
Title
Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review
Authors
Ricardo G. Suarez
Alvaro R. Osornio-Vargas
Eytan Wine
Publication date
25-06-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07597-3

Other articles of this Issue 9/2022

Digestive Diseases and Sciences 9/2022 Go to the issue

Original Article

Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population

Original Article

Helicobacter pylori Management Is Associated with Predominantly Negative Patient Experiences: Results from a Focused Qualitative Analysis

Correspondence

Methodological Insight to the High-Flow Nasal Cannula Oxygenation in Elderly Undergoing Endoscopic Retrograde Cholangiopancreatography

FELLOWS AND YOUNG GIS SECTION

Advanced Fellowship Training in IBD: A Worthwhile Fourth Year

Image of the Month

IgG4-Related Disease with Hypophysitis and Cholangitis as the Main Manifestations

Original Article

Fine Needle Biopsies of Solid Pancreatic Lesions: Tissue Acquisition Technique and Needle Design Do Not Impact Specimen Adequacy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits